Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”
Authors
Thomas Decramer (ORCID: https://orcid.org/0000-0002-2585-581X)
Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”
Thomas Decramer, Hilde Brems, Ellen Denayer, Christophe M. Deroose et al.
Journal
Cancers
Topics
Neurofibromatosis and Schwannoma Cases
article
Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”
Thomas Decramer, Hilde Brems, Ellen Denayer, Christophe M. Deroose, Dries Ruttens, Vincent Vandecaveye, Eric Legius, Daphne Hompes, Thomas Douchy, Sandra Jacobs, Raf Sciot, Frank Van Calenbergh, Maria Pia Iasella